Wells Fargo & Company MN Purchases 75,465 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Wells Fargo & Company MN increased its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHFree Report) by 87.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 161,697 shares of the company’s stock after purchasing an additional 75,465 shares during the quarter. Wells Fargo & Company MN owned 3.08% of SPDR S&P Pharmaceuticals ETF worth $6,730,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. BNP Paribas Financial Markets lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 1,011.6% in the fourth quarter. BNP Paribas Financial Markets now owns 56,658 shares of the company’s stock worth $2,358,000 after acquiring an additional 51,561 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth about $1,938,000. LPL Financial LLC lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 26.4% in the third quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock worth $4,960,000 after acquiring an additional 26,031 shares during the last quarter. VCI Wealth Management LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter worth about $515,000. Finally, U.S. Capital Wealth Advisors LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter worth about $495,000.

SPDR S&P Pharmaceuticals ETF Trading Down 0.4 %

XPH stock opened at $40.61 on Friday. The stock has a market capitalization of $196.96 million, a P/E ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 12 month low of $34.67 and a 12 month high of $45.62. The firm has a 50-day moving average price of $40.66 and a 200-day moving average price of $41.37.

SPDR S&P Pharmaceuticals ETF Company Profile

(Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHFree Report).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.